Scalable cell culture and transient transfection for viral vector manufacturing

Cell & Gene Therapy Insights 2021; 7(9), 1035


Published: 20 September 2021
Ann Rossi Bilodeau

Watch the video or read the poster to learn:

  • Challenges for scalable viral vector production
  • Considerations for choosing a cell culture platform
  • Best practices for transient transfection of adherent cultures
  • Guidance for transfection of Corning CellSTACK®️and Corning CellCube platforms with Polyplus PEIpro®️ transfection reagent

Ann Rossi Bilodeau graduated from the University of Rochester School of Medicine and Dentistry with a PhD in Pharmacology and received postdoctoral training at the University of Chicago. Ann began her career with Corning Life Sciences as the Applications Lab Manager where she utilized her strong academic and industry research experience to direct the activities of the Applications Laboratory. Currently, Dr Rossi Bilodeau is the Senior Bioprocess Applications Scientist, functioning as the technical lead for generating applications in support of Corning Life Sciences’ Bioprocess and Cell and Gene Therapy portfolios including the Corning®️ CellCube®️ and Corning HYPERStack®️ platforms.